Literature DB >> 16264954

Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?

Gabriel Capellá1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16264954     DOI： 10.1038/ncponc0170

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  2 in total

1.  What is a Reasonable Screening Test for Colorectal Cancer.

Authors:  Young Jin Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-12-31

2.  Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.

Authors:  R Mayor; L Casadomé; D Azuara; V Moreno; S J Clark; G Capellà; M A Peinado
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.